Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP113232.RAJWhS-lFuxoZ3cr2mGvN2DO_dxt9O0V0pKsWVqED6slw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP113232.RAJWhS-lFuxoZ3cr2mGvN2DO_dxt9O0V0pKsWVqED6slw130_assertion type Assertion NP113232.RAJWhS-lFuxoZ3cr2mGvN2DO_dxt9O0V0pKsWVqED6slw130_head.
- NP113232.RAJWhS-lFuxoZ3cr2mGvN2DO_dxt9O0V0pKsWVqED6slw130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP113232.RAJWhS-lFuxoZ3cr2mGvN2DO_dxt9O0V0pKsWVqED6slw130_provenance.
- NP113232.RAJWhS-lFuxoZ3cr2mGvN2DO_dxt9O0V0pKsWVqED6slw130_assertion evidence source_evidence_literature NP113232.RAJWhS-lFuxoZ3cr2mGvN2DO_dxt9O0V0pKsWVqED6slw130_provenance.
- NP113232.RAJWhS-lFuxoZ3cr2mGvN2DO_dxt9O0V0pKsWVqED6slw130_assertion SIO_000772 20959405 NP113232.RAJWhS-lFuxoZ3cr2mGvN2DO_dxt9O0V0pKsWVqED6slw130_provenance.
- NP113232.RAJWhS-lFuxoZ3cr2mGvN2DO_dxt9O0V0pKsWVqED6slw130_assertion wasDerivedFrom gad-20150221 NP113232.RAJWhS-lFuxoZ3cr2mGvN2DO_dxt9O0V0pKsWVqED6slw130_provenance.
- NP113232.RAJWhS-lFuxoZ3cr2mGvN2DO_dxt9O0V0pKsWVqED6slw130_assertion wasGeneratedBy ECO_0000203 NP113232.RAJWhS-lFuxoZ3cr2mGvN2DO_dxt9O0V0pKsWVqED6slw130_provenance.